Despite the smaller sample size of the validation cohort, 24.6% of CpG sites showed consistent and nominally significant effects.
← all excerpts
Epigenome-wide Mendelian randomization with multi-omics validation identifies epigenetic drivers of idiopathic pulmonary fibrosis.
1
—
—